Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
How Does The Market Size Of The Non-PVC IV Bags Industry Compare Between 2025 And 2029?
Strong expansion has characterized the non-PVC IV bags market recently, projecting a rise from $1.79 billion in 2024 to $1.95 billion the following year, reflecting a compound annual growth rate of 9.2%; this upward trajectory during the review period stems from the increasing requirement for non-toxic packaging solutions for pharmaceuticals, greater incidence of chemotherapy treatments, the widespread occurrence of chronic kidney ailments, escalating unsatisfied healthcare demands, and a growing elderly demographic.
Projections indicate that the market for non-PVC intravenous bags is poised for substantial expansion over the upcoming years, achieving a valuation of $2.73 billion by 2029, driven by an 8.8% compound annual growth rate; this robust expansion throughout the forecast horizon is fueled by factors such as the escalating prevalence of cancer, the proliferation of healthcare facilities including hospitals and outpatient centers, a greater influx of patients accessing medical services, supportive government programs, and the growing imperative to implement safeguards against medical errors, while key shifts shaping this period encompass burgeoning infrastructure improvements across the healthcare domain, the introduction and accessibility of contemporary materials fashioned in diverse configurations, advancements in service technology, escalating requirements for sophisticated containment solutions, and a preference shift toward utilizing single-chambered non-PVC IV bags.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15621&type=smp
What Are The Main Drivers Boosting The Non-PVC IV Bags Industry’s Expansion?
Elevated volumes of individuals seeking medical attention across various healthcare environments are anticipated to fuel the expansion of the market for intravenous (IV) bags not made from polyvinyl chloride (PVC). This patient traffic essentially signifies the quantity or movement of people requiring medical attention or services within facilities like hospitals, clinics, or physician offices. Increased healthcare admissions are a result of greater demand for medical services, coupled with shifts in healthcare regulations or insurance provisions. Non-PVC IV bags are utilized because of worries surrounding potentially hazardous substances leaching from PVC materials into solutions administered intravenously, thereby reducing the likelihood of patients encountering toxins. To illustrate, data from the National Health Service, the UK’s publicly financed healthcare entity, indicated in a January 2024 publication that 1.63 million patients began treatment in November 2023 while over 2.3 million diagnostic procedures were performed, exerting substantial strain on accident and emergency services nationally, where more than 2.1 million A&E attendances and above 547,000 emergency admissions were recorded in December 2023. Consequently, the rising flow of patients through healthcare facilities serves as a catalyst for the market’s advancement in non-PVC IV bags.
What Are The Different Segment Classifications Within The Non-PVC IV Bags Market?
The non-pvc iv bagsmarket covered in this report is segmented –
1) By Product: Single Chamber, Multi Chamber
2) By Material: Ethylene Vinyl Acetate, Polypropylene, Copolyester Ether, Other Materials
3) By Content: Frozen Mixture, Liquid Mixture
4) By Application: Chemotherapy, Targeted Drug Delivery, Glucose Injection, Sodium Chloride Solution, Electrolyte Injection, Nutrient Injection, Other Applications
5) By End User: Hospitals, Clinics, Emergency Service Centers, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Single Chamber: Standard Single Chamber Iv Bags, Flexible Single Chamber Iv Bags
2) By Multi Chamber: Dual Chamber Iv Bags, Triple Chamber Iv Bags, Multi-Camber Iv Bags (More Than Three Chambers)
Which Key Trends Are Expected To Influence The Non-PVC IV Bags Market In The Coming Years?
Leading firms engaged in the non-PVC intravenous bag sector are actively engineering novel packaging solutions, specifically incorporating polyolefin shrink films to boost safety standards, environmental friendliness, and suitability across a spectrum of intravenous fluids.These polyolefin shrink films serve as robust, adaptable, and transparent packaging media, frequently employed for providing secure, tamper-evident sealing across numerous industries including perishables, retail consumables, electronic devices, and pharmaceuticals; moreover, their inherent non-toxicity coupled with superior resistance to punctures render them perfectly suited for environments involving fluctuating temperatures.To illustrate this advancement, in February of 2024, Innovia Films, a global producer and distributor of biaxially-oriented polypropylene film situated in the United Kingdom, introduced RayoFloat white APO, which constitutes a buoyant, opaque, low-density polyolefin shrink film specifically formulated for safeguarding products sensitive to light; this material possesses distinguishing characteristics such as facilitating effortless label separation during PET recycling processes, thereby contributing to the creation of superior-grade, food-safe PET flakes, while its opacity ensures crucial light-blocking properties beneficial for goods like dairy items, nutritional supplements, and cosmetics, further underscoring a commitment to sustainability through the integration of as much as 20% post-industrial recycled material and adherence to the European Union’s Packaging and Packaging Waste Regulation (PPWR).
Which Leading Companies Dominate The Non-PVC IV Bags Market Share?
Major companies operating in the Non-PVC IV bags market are Cardinal Health Inc., Pfizer Inc., Abbott Laboratories, Medline Industries LP, Becton Dickinson and Company, Otsuka Pharmaceutical Co. Ltd., Baxter International Inc., B. Braun Melsungen AG, Fresenius Kabi AG, Grifols S.A., Terumo Corporation, Sealed Air Corporation, Nipro Corporation, ICU Medical Inc., Kraton Corporation, Haemonetics Corporation, JW Life Science, Jiangxi Sanxin Medtec Co. Ltd., Persico S.p.a., Angiplast Pvt. Ltd., Fagron Sterile Services, Technoflex SA, Medi Pharma Plan Co. Ltd., Bausch Advanced Technologies Inc., PolyCine GmbH
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/non-pvc-iv-bags-global-market-report
How Do Regional Market Performances Compare Within The Non-PVC IV Bags Industry?
North America was the largest region in the non-PVC IV bags market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the Non-PVC IV bags market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Non-PVC IV Bags Market Report:
https://www.thebusinessresearchcompany.com/customise?id=15621&type=smp
Browse Through More Reports Similar to the Global Non-PVC IV Bags Market 2025, By The Business Research Company
Medical Specialty Bags Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/medical-specialty-bags-global-market-report
Bioprocess Bags Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/bioprocess-bags-global-market-report
Disposable Intestinal Wash Bags Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
